Gain Therapeutics

GANX

Capitalización de mercado USD 56.3 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
26	26 Bridgeway Capital Management Houston, Texas	USD 60.9 k	–	–	–
27	27 Apollon Wealth Management Mount Pleasant, South Carolina	USD 53.8 k	–	–	–
28	28 Virtu Financial New York	USD 43 k	+USD 19 k	+10,330	+97%
29	29 Oliver Luxxe Assets Gladstone, New Jersey	USD 41.1 k	–	–	–
30	30 Vanguard Global Advisers Malvern, Pennsylvania	USD 37.3 k	–	–	–
31	31 HighTower Advisors Chicago, Illinois	USD 34.9 k	+USD 31.7 k	+17,174	Nuevas
32	32 Wealthspire Advisors (New York) New York	USD 34.3 k	–	–	–
33	33 Sandhill Capital Partners Buffalo, New York	USD 31.3 k	–	–	–
34	34 Wealth Enhancement Advisory Services Plymouth, Minnesota	USD 30.7 k	+USD 2.76 k	+1,500	+10%
35	35 HB Wealth Management Atlanta, Georgia	USD 25.9 k	+USD 23.6 k	+12,783	Nuevas
36	36 Two Sigma Securities New York	USD 25.9 k	+USD 23.5 k	+12,739	Nuevas
37	37 Millington Financial Advisors Naperville, Illinois	USD 25.6 k	–	–	–
38	38 Harbour Investments Madison, Wisconsin	USD 21.8 k	+USD 19.8 k	+10,745	Nuevas
39	39 NewEdge Advisors New Orleans, Louisiana	USD 21.5 k	–	–	–
40	40 Mercer Global Advisors Denver, Colorado	USD 20.3 k	+USD 18.4 k	+10,000	Nuevas
41	41 Sanctuary Advisors Indianapolis, Indiana	USD 20.3 k	+USD 18.4 k	+10,000	Nuevas
42	42 Wells Fargo San Francisco, California	USD 19.1 k	-USD 3.04 k	-1,650	-15%
43	43 Tower Research Capital (TRC) New York	USD 16.9 k	+USD 5.19 k	+2,815	+51%
44	44 Group One Trading Chicago, Illinois	USD 7.73 k	-USD 4.78 k	-2,596	-41%
45	45 Osaic Holdings Scottsdale, Arizona	USD 4.06 k	+USD 3.69 k	+2,000	Nuevas
46	46 Arax Advisory Partners Denver, Colorado	USD 3.45 k	+USD 3.13 k	+1,700	Nuevas
47	47 JP Morgan Chase New York	USD 3.37 k	–	–	–
48	48 Barclays London, United Kingdom	USD 2.74 k	+USD 2.49 k	+1,352	Nuevas
49	49 Caitong International Asset Management Hong Kong	USD 335	+USD 304	+165	Nuevas
50	50 Larson Financial Group St Louis, Missouri	USD 20	–	–	–

Gain Therapeutics GANX Capitalización de mercado USD 56.3 M

Gain Therapeutics

GANX

Capitalización de mercado USD 56.3 M